NEW YORK, July 12, 2016 /PRNewswire/ — EpiCast Report: Form 2 Diabetes – Epidemiology Forecast to 2025
Summary
Type 2 diabetes (T2D), formerly referred to as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that outcomes from the body’s inability to make usage of offered insulin along along with relative insulin deficiency. T2D constitutes around 90% of all of diabetes cases about the world; Form 1 diabetes (T1D) and gestational diabetes comprise the remaining 10% of the cases. Risk factors for T2D are broadly categorized as either modifiable or non-modifiable risk factors. Way of life factors such as obesity, bodily inactivity, and dietary habits are modifiable risk factors, whereas family history and advancing age are non-modifiable risk factors. T2D is additionally associated along with several comorbidities, such as CKD, CVD, hypertension, and dyslipidemia, which can easily worsen the quality of life of the patient, and can easily cause unsatisfactory therapeutic outcomes. Diabetes is among the many common non-communicable diseases international and is an escalating public good health problem globally.
GlobalData epidemiologists forecast an raise in the diagnosed prevalent cases of T2D in the 9MM, from 116,871,808 diagnosed prevalent cases in 2015 to 151,907,657 diagnosed prevalent cases in 2025, along with an Annual Growth Fee (AGR) of 3.00%. The projected raise in the diagnosed prevalent cases of T2D across all of the markets covered in this analysis is attributed to the real raise in the incidence of T2D along along with the adjustment in population demographics in the respective markets.
GlobalData epidemiologists utilized country-personal diagnosed prevalence data for T2D across the 9MM. Additionally, the epidemiological forecast for the diagnosed prevalent cases of T2D in the 9MM is supported by nationally representative longitudinal historical data obtained from studies in respective countries published in peer-reviewed journals or national healthcare databases, which offer a detailed recommendations in to the epidemiology of the health problem in these markets.
Scope
– The Form 2 Diabetes (T2D) EpiCast Report offers an overview of the risk factors and global trends of T2D in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and India). It entails a 10-year epidemiology forecast of T2D diagnosed prevalent cases segmented by age (in ten-year increments start at ages 20-30 years and ending at age 80 years and older), sex, and comorbidities including chronic kidney health problem (CKD), cardio health problem (CVD), overweight/obesity, hypertension, and dyslipidemia in these nine markets.
– The T2D epidemiology report is written and made by Masters- and PhD-degree epidemiologists.
– The EpiCast Report is in-depth, higher quality, transparent and market-driven, providing expert analysis of health problem trends in the 9MM.
Reasons to buy
The T2D EpiCast report will certainly enable you to –
– create firm strategies by learning the trends shaping and driving the global T2D market.
– Quantify patient populations in the global T2D market to increase product design, pricing, and launch plans.
– Organize sales and marketing efforts by determining the age teams and sex that present the very best chances for T2D therapeutics in each of the markets covered.
– Identify the percentage of T2D diagnosed prevalent cases by age, sex, and comorbidities.
Read the complete report: http://ift.tt/29Op3kO
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the current industry data so you grab all of the market research you demand – instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To see the original version on PR Newswire, visit:http://ift.tt/29Ooyar
